Khwaja Omar — SEC insider filings

SEC reporting owner CIK 1776393. 6 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2021-02-16 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Voyager Therapeutics, Inc. (VYGR)See remarks4—2 legs · 6,991 sh · $40,4063
WINDWARD BIO GROUP AG (WWB)Chief Medical Officer2——1

Insider filings — Khwaja Omar

FiledFormIssuerReported transactionsSource
2026-11-164WINDWARD BIO GROUP AG (WWB)Grant/award (A): 219,030 (derivative) @ $0EDGAR
2026-11-123WINDWARD BIO GROUP AG (WWB)Holdings only — no transactions reportedEDGAR
2021-05-254Voyager Therapeutics, Inc. (VYGR)Sale (S): 3,516 @ $4.03EDGAR
2021-03-234Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 35,000 @ $0EDGAR
2021-02-184Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 36,000 @ $0 · Grant/award (A): 72,000 (derivative) @ $0EDGAR
2021-02-164Voyager Therapeutics, Inc. (VYGR)Sale (S): 3,475 @ $7.55EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1776393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs